Open AccessDurable response to afatinib in an advanced lung adenocarcinoma patient with an EGFR L858R/G729A compound mutation: a case report
Author(s) -
Lige Wu,
Cheng Fang,
Weiqing Zhao,
Dong Li,
Shuxian Tang,
Xi Li,
Mei Ji
Publication year - 2022
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-22-95
Subject(s) - afatinib , t790m , medicine , osimertinib , epidermal growth factor receptor , adenocarcinoma , lung cancer , gefitinib , oncology , erlotinib , mutation , cancer research , cancer , biology , gene , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom